Related Experiment Videos

[Slow-release theophyllines: serum and saliva levels in asthmatic children]

I Souto Martínez1, J Duque Hernández, L Galván Tudela

  • 1Servicio de Laboratorio, Hospital de Niños, Santa Cruz de Tenerife.

Insights

This study determined the average daily dose of slow-release theophylline for children with extrinsic asthma. Salivary theophylline levels showed a strong correlation with serum levels, suggesting a potential monitoring tool.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacokinetics
  • Asthma Management

Context:

  • Extrinsic asthma is a common respiratory condition in children.
  • Theophylline is a bronchodilator used in asthma treatment.
  • Maintaining therapeutic serum theophylline concentrations is crucial for efficacy and safety.

Purpose:

  • To establish the average dose of slow-release theophylline required for therapeutic serum concentrations in children aged 5-13 with extrinsic asthma.
  • To investigate the correlation between salivary and serum theophylline levels.
  • To assess the efficacy of a 12-hour dosing regimen of slow-release theophylline.

Summary:

  • Forty-two children with extrinsic asthma received slow-release theophylline.
  • Average doses were 20.14 mg/kg/day for under-9s and 19.00 mg/kg/day for older children.
  • A strong linear correlation (r=0.89, p<0.001) was found between salivary and serum theophylline levels, with the regression equation Se = 1.52.Sa + 0.75.

Impact:

  • The 12-hour dosing regimen effectively maintained therapeutic theophylline levels in most pediatric asthma patients.
  • Salivary theophylline levels offer a promising, non-invasive method for monitoring treatment in children.
  • Findings contribute to optimizing theophylline therapy for pediatric asthma.

Related Concept Videos